Bosh sahifa1LNTH • BIT
add
Lantheus Holdings Inc
Yopilish kursi
48,93 €
Yillik diapazon
42,02 € - 95,18 €
Bozor kapitalizatsiyasi
3,81 mlrd USD
Oʻrtacha hajm
14,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NASDAQ
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 378,04 mln | -4,07% |
Joriy xarajat | 153,04 mln | 0,00% |
Sof foyda | 78,76 mln | 26,87% |
Sof foyda marjasi | 20,83 | 32,25% |
Har bir ulushga tushum | 1,57 | -12,78% |
EBITDA | 101,20 mln | -13,91% |
Amaldagi soliq stavkasi | 24,65% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 695,57 mln | -8,12% |
Jami aktivlari | 2,12 mlrd | 9,09% |
Jami passivlari | 949,29 mln | 3,96% |
Umumiy kapital | 1,17 mlrd | — |
Tarqatilgan aksiyalar | 67,99 mln | — |
Narxi/balansdagi bahosi | 2,85 | — |
Aktivlardan daromad | 10,54% | — |
Kapitaldan daromad | 12,35% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | iyn, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 78,76 mln | 26,87% |
Operatsiyalardan naqd pul | 87,11 mln | 2,82% |
Sarmoyadan naqd pul | -232,47 mln | -415,62% |
Moliyadan naqd pul | -98,41 mln | -99 507,07% |
Naqd pulning sof oʻzgarishi | -242,95 mln | -726,97% |
Boʻsh pul | 86,28 mln | 164,00% |
Haqida
Lantheus, headquartered in Billerica, Massachusetts, is a company in the radiopharmaceuticals business. It has strategic partnerships with Bayer, Novartis, Regeneron as well as GE Healthcare and Siemens Healthineers.
Lantheus Holding, which became a NASDAQ company in 2015, is the parent company of Lantheus Medical Imaging, Inc., Progenics Pharmaceuticals, Inc. and EXINI Diagnostics AB. Lantheus has offices in Massachusetts, New Jersey, Canada and Sweden.
Brian Markison has served as the company's CEO since March 1, 2024, following the retirement of Mary Anne Heino, who had led Lantheus for the preceding decade. Wikipedia
Tashkil etilgan
1956
Sayt
Xodimlar soni
808
